Research
/
Stock
/
CVS
C
CVS
CVS HEALTH Corp
FY2025
i
Mkt cap 118.2B
92.90
-1.21 -1.29%
close 2026-08-25
i
Overview
Financials
Insider
DCF
Research
/
Stock
/
…
Pulling SEC filings & building this page… the first lookup of a new ticker takes a few seconds, then it's cached.
Mkt Cap
i
118.2B
P/E
i
66.8
Revenue FY2025
i
402.1B
Gross Margin
i
45.0%
FCF FY2025
i
7.8B
Net Income
i
1.8B
52-week range
i
70.08
-16.0% off high
i
110.60
Beta
i
0.45
vs S&P 500 · 1232 common days
Dividend
i
2.87%
$3.4B paid in FY2025 · on today's cap
Price
i
1M
6M
1Y
5Y
i
i
Revenue
i
402.1B
FY2025
i
·
+7.8% YoY
i
i
EBITDA
i
9.3B
FY2025 · operating + D&A
Free Cash Flow
i
7.8B
FY2025
i
·
+23.4% YoY
i
i
EPS (diluted)
i
1.39
FY2025
i
·
-62.0% YoY
i
i
Earnings
i
next est.
Last reported
5 Aug 2026 · 8-K (2.02)
Next report
≈ 4 Nov 2026
Moat & Risks
i
Engine pending
45.0% gross margin (FY2025) — pricing-power signal.
FY2025 10-K ›
Revenue +7.85% YoY to 402.1B (FY2025).
FY2025 10-K ›
Sourced moat / risk brief — generated by the Silkcodex engine (pending run).
Insider activity
i
12 Form 4 · 0 open-market buys vs 7 sells
i
All transactions →
−317M
net open-market
i
2026-06-26
F
Clark James David
· SVP, Cont & Chief Acct Officer
Tax withhold
454
41K
2026-05-31
F
Newman Brian
· EVP, Chief Financial Officer
Tax withhold
2,478
225K
2026-05-31
F
Compton-Phillips Amy
· EVP, Chief Medical Officer
Tax withhold
7,618
693K
2026-05-21
D
Aguirre Fernando
· Director
D
1,563
146K
2026-05-21
S
Robbins Larry
· Director
Sell
370,462
35M
Recent filings
8 on file · SEC EDGAR
i
2026-08-05
10-Q
Quarterly report
EDGAR ›
2026-08-05
8-K
Earnings results · Exhibits
EDGAR ›
2026-05-18
8-K
Officer / director change · Shareholder vote
EDGAR ›
2026-05-06
10-Q
Quarterly report
EDGAR ›
2026-05-06
8-K
Earnings results · Exhibits
EDGAR ›